COMBINATION THERAPY WITH MITOMYCIN-C, 5-FLUOROURACIL, AND CYTOSINE-ARABINOSIDE IN P815 ASCITES AND SOLID MOUSE NEOPLASMS

被引：0
|
作者：
KREIS, W [1 ]
机构：
[1] MEMORIAL SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
来源：
CANCER TREATMENT REPORTS | 1976年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1399 / 1400
页数：2
相关论文
共 50 条
  • [1] COMBINATION CHEMOTHERAPY WITH MITOMYCIN-C, 5-FLUOROURACIL, AND CYTOSINE-ARABINOSIDE IN GASTROINTESTINAL CANCER
    DEJAGER, RL
    MAGILL, GB
    GOLBEY, RB
    KRAKOFF, IH
    CANCER TREATMENT REPORTS, 1976, 60 (09): : 1373 - 1375
  • [2] MITOMYCIN-C, 5-FLUOROURACIL AND CYTOSINE-ARABINOSIDE (MFC) IN GASTROINTESTINAL CANCER
    DEJAGER, R
    MAGILL, GB
    GOLBEY, RB
    KRAKOFF, IH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 178 - 178
  • [3] COMBINATION THERAPY WITH MITOMYCIN-C, 5-FLUOROURACIL, AND CYTOSINE-ARABINOSIDE FOR NON-RESECTABLE MALIGNANT-TUMOR IN MAN
    YAMAGUCHI, T
    NAKAMURA, M
    JOURNAL OF SURGICAL ONCOLOGY, 1978, 10 (05) : 417 - 429
  • [4] CHEMOTHERAPY FOR COLORECTAL CANCER WITH A COMBINATION OF 5-FLUOROURACIL, MITOMYCIN-C, ADRIAMYCIN, AND CYTOSINE-ARABINOSIDE - PILOT-STUDY
    DAVIS, S
    PARK, YK
    CANCER TREATMENT REPORTS, 1978, 62 (10): : 1557 - 1559
  • [5] ADJUVANT CHEMOTHERAPY WITH MITOMYCIN-C, AND WITH A MULTI-DRUG COMBINATION OF MITOMYCIN-C, 5-FLUOROURACIL AND CYTOSINE-ARABINOSIDE AFTER CURATIVE RESECTION OF GASTRIC-CANCER
    NAKAJIMA, T
    FUKAMI, A
    TAKAGI, K
    KAJITANI, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1980, 10 (02) : 187 - 194
  • [6] CHEMOIMMUNOTHERAPY OF ADVANCED GASTRIC CANCER - MITOMYCIN-C, 5-FLUOROURACIL, AND CYTOSINE-ARABINOSIDE (MIFUCA) WITH AND WITHOUT C-PARVUM
    LIGHTDALE, CJ
    MAGILL, GB
    PINSKY, C
    SHERLOCK, P
    GOLBEY, RB
    GASTROENTEROLOGY, 1976, 70 (05) : 958 - 958
  • [7] ADRIAMYCIN (A), 5-FLUOROURACIL + MITOMYCIN-C + CYTOSINE-ARABINOSIDE (F M C), AND 5-FLUOROURACIL + ADRIAMYCIN + METHYL CCNU (F A ME) IN ADVANCED GASTRIC CARCINOMA
    OCONNELL, MJ
    MOERTEL, CG
    LAVIN, PT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 343 - 343
  • [8] COMBINATION THERAPY WITH MITOMYCIN-C (NSC-26980), 5-FLUOROURACIL (NSC-19893), AND CYTOSINE-ARABINOSIDE (NSC-63878) FOR ADVANCED CANCER IN MAN
    OTA, K
    OYAMA, A
    NISHIMURA, M
    OGAWA, M
    AMO, H
    ARIYOSHI, Y
    KATAOKA, K
    KATO, T
    KAMEI, Y
    IMAI, K
    MURAKAMI, M
    HOSHINO, A
    KURITA, S
    CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (03): : 373 - +
  • [9] MITOMYCIN-C, 5-FU, AND CYTOSINE-ARABINOSIDE (MIFUCA) IN ADENOCARCINOMAS
    YAGODA, A
    LIPPMAN, A
    WINN, R
    ROSENBER.A
    SCHULMAN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 190 - 190
  • [10] EFFECT OF CYTOSINE-ARABINOSIDE AND 5-FLUOROURACIL ALONE AND IN COMBINATION ON P1798 SENSITIVE AND RESISTANT TO STEROID LYMPHOMAS IN SAME MOUSE
    ASAM, JL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 122 - 122
12345